Ibrutinib vs chlorambucil in CLL patients not suitable for chemotherapy
Developing safe and effective agents for the treatment of CLL
The influence of the European Research Initiative on CLL (ERIC)
Benefits of deacetylase inhibitors for leukemia therapy
What are the benefits of having different chronic lymphocytic leukemia (CLL) treatment options?